Financial Update Spring 2026

Summary by AI ^BETAClose X

PenArian Housing Finance PLC reported strong performance for the 2025/26 fiscal year, with an operating surplus of £14 million and an operating margin of 20.9%, alongside a net surplus of £4.8 million and a margin of 7.1%. The company successfully completed the sale of its nursing home, Merton Place, which is expected to improve operating margins in future years despite reducing turnover. Cashflow was bolstered by a new flexible loan arrangement with Principality and an extension of their credit line for an additional five years. PenArian Housing Finance PLC also maintained its 'A Stable' credit rating from Standard and Poor's and an A3 'stable' rating from Moody's, and received a green status from Welsh Government for Governance, Service Delivery, and Financial Viability.

Disclaimer*

PenArian Housing Finance PLC

11 March 2026

A white and blue logo Description automatically generated with medium confidence

Financial Update - March 2026

PenArian Housing Finance PLC

Overview

ClwydAlyn continued to perform well throughout 2025/26 and the quarter 3 Management Accounts show strong and consistent performance against budget. Of particular note is the improvement in the management of empty properties reducing the rent losses as a result and the increase in volume of shared ownership staircasing and sales reflecting a positive market. With an ambitious development programme and a changing grant receipt profile from Welsh Government, additional drawdown of funds has been made and interest paid has therefore increased.

The sale of our only nursing home also completed in Q3. Merton Place was sold to Minster Care, an organisation with expertise in this sector and in whom the Board found assurance that our residents and colleagues would continue to be well cared for. This transaction reduces complexity and risk from the organisation and improves operating margin due to the tight business model in the nursing sector. ClwydAlyn continues to support older adults through our Extra Care schemes and Care Home portfolio. The disposal results in lower turnover for ClwydAlyn, but stronger operating margins. The impact of this in 2025/26 is reduced due to the timing of the completion towards the end of the year, however it does support the margins in future years.

The result is a strong full year forecast with an operating surplus of £14 million and an operating margin of 20.9% and a net surplus of £4.8million and margin of 7.1%.

Cashflow

We completed a further flexible loan arrangement with Principality, a Welsh lender in Q3 which provided funds to support our planned development programme. Following the annual review of our Treasury Strategy we are increasing the Group's committed credit line to enhance liquidity and extending the facility for an additional five years.

Rating

We were pleased to retain our 'A Stable' credit rating with Standard and Poor's and Moody's rating of A3 'stable'.

Regulation

We are pleased to announce that ClwydAlyn received its Welsh Government Regulatory Judgement in December 2025 confirming our green status for both Governance and Service Delivery and Financial Viability. Full details of the Judgement can be found on our investors page. Investors2 - Clwydalyn

Should you have any queries regarding this update you can contact:

Company Secretary rachel.storr-barber@clwydalyn.co.uk
Executive Director of Resources sandy.murray@clwydalyn.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END